Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
Surgery
|
October 18, 2024
Intraoperative hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma without preoperative medical preparation compared with nonsecreting tumor
Claire Nomine-Criqui, Amélie Delens, Phi-Linh Nguyen-Thi, et al.
Annales D'Endocrinologie
|
January 16, 2025
Chapter 3: Impact of primary hyperparathyroidism
Nicolas Scheyer, Samuel Frey, Eugénie Koumakis, et al.
Diabetes, Obesity & Metabolism
|
January 20, 2025
Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network
Sophie Lamothe, Ines Belalem, Marie-Christine Vantyghem, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 19, 2025
Real-world osilodrostat effectiveness and safety in non-pituitary Cushing syndrome
Antoine Tabarin, Jérôme Bertherat, Bénédicte Decoudier, et al.
European Journal of Endocrinology
|
May 6, 2022
Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?
Lucie Coppin, Sophie Giraud, Eric Pasmant, et al.
Annales D'Endocrinologie
|
September 1, 2025
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM
Marie-Christine Vantyghem, Eric Mirallié, Abdallah Al-Salameh, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
Surgery
|
October 18, 2024
Intraoperative hemodynamic instability during laparoscopic adrenalectomy for pheochromocytoma without preoperative medical preparation compared with nonsecreting tumor
Claire Nomine-Criqui, Amélie Delens, Phi-Linh Nguyen-Thi, et al.
Annales D'Endocrinologie
|
January 16, 2025
Chapter 3: Impact of primary hyperparathyroidism
Nicolas Scheyer, Samuel Frey, Eugénie Koumakis, et al.
Diabetes, Obesity & Metabolism
|
January 20, 2025
Safety and effectiveness in an uncontrolled setting of glucagon-like-peptide-1 receptor agonists in patients with familial partial lipodystrophy: Real-life experience from a national reference network
Sophie Lamothe, Ines Belalem, Marie-Christine Vantyghem, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 19, 2025
Real-world osilodrostat effectiveness and safety in non-pituitary Cushing syndrome
Antoine Tabarin, Jérôme Bertherat, Bénédicte Decoudier, et al.
European Journal of Endocrinology
|
May 6, 2022
Multiple endocrine neoplasia type 1 caused by mosaic mutation: clinical follow-up and genetic counseling?
Lucie Coppin, Sophie Giraud, Eric Pasmant, et al.
Annales D'Endocrinologie
|
September 1, 2025
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM
Marie-Christine Vantyghem, Eric Mirallié, Abdallah Al-Salameh, et al.
Page
of 2